Skip to Main Content

Paper Details

Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers.
Oncotarget
10
2016
Author NameAffiliation
Marshall Scott LuciaUniversity of Colorado School of Medicine
Christopher C PorterUniversity of Colorado School of Medicine
  • 1 - 2

Datasets

Release 1.2